Takao Isogai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Takao Isogai has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Hideo Takahashi
6 shared publicationsHiuga Saito
6 shared publicationsAi Wakamatsu
Japan Biological Informatics Consortium (JBiC), Koto-ku, Tokyo, Japan
2 shared publicationsJun-Ichi Imai
Translational Research Center, Fukushima Medical University, Fukushima 960-1295, Japan
2 shared publicationsMasanobu Kohsaka
Pharmacological Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., 1-6, 2-chome, Kashima, Yodogawa-ku, Osaka 532, Japan
2 shared publicationsMasao Fukagawa
2 shared publications
Latest Publications
- Open Access
- 1 March 2021
- Published by Elsevier in Translational Oncology
- Vol. 14 (3) , 101010
Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma
- 1 March 2021
- Published by Elsevier in Translational Oncology
- Vol. 14 (3) , 101010
Open AccessClinical relevance of oncogenic driver mutations identified in endometrial carcinoma
- Open Access
- 23 April 2020
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 16 (4) , e1008469
Non-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter
The molecular mechanisms that allow pathogenic bacteria to infect animals have been intensively studied. On the other hand, the molecular mechanisms by which bacteria acquire virulence functions are not fully understood. In the present study, we experimentally evaluated the evolution of a non-pathogenic strain of Escherichia coli in a silkworm infection model and obtained pathogenic mutant strains. As one cause of the high virulence properties of E. coli mutants, we identified amino acid substitutions in LptD (G580S) and LptE (T95I) constituting the lipopolysaccharide (LPS) transporter, which translocates LPS from the inner to the outer membrane and is essential for E. coli growth. The growth of the LptD and LptE mutants obtained in this study was indistinguishable from that of the parent strain. The LptD and LptE mutants exhibited increased secretion of outer membrane vesicles containing LPS and resistance against various antibiotics, antimicrobial peptides, and host complement. In vivo cross-linking studies revealed that the conformation of the LptD-LptE complex was altered in the LptD and LptE mutants. Furthermore, several clinical isolates of E. coli carried amino acid substitutions of LptD and LptE that conferred resistance against antimicrobial substances. This study demonstrated an experimental evolution of bacterial virulence properties in an animal infection model and identified functional alterations of the growth-essential LPS transporter that led to high bacterial virulence by conferring resistance against antimicrobial substances. These findings suggest that non-pathogenic bacteria can gain virulence traits by changing the functions of essential genes, and provide new insight to bacterial evolution in a host environment. Pathogenic bacteria developed their virulence properties by changing the functions of various genes after the emergence of the host animals on earth. The types of gene function alterations that confer bacterial virulence properties, however, have remained unclear. We utilized a silkworm infection model to perform an experimental evolution of bacterial virulence activity. From a non-pathogenic strain of Escherichia coli, we obtained a mutant strain that exhibited 500-fold higher virulence than the original strain and identified mutations of the lipopolysaccharide (LPS) transporter, which translocates LPS onto the bacterial surface, as one cause of the high virulence. The mutations changed the structure of the LPS transporter, increased the secretion of outer membrane vesicles, and enabled bacterial survival in the presence of host antimicrobial substances. This mechanism to gain high virulence occurs naturally, as several E. coli clinical isolates carried mutations of the LPS transporter that confer resistance against antimicrobial substances. Our study unveiled a novel mechanism by which bacteria increase their virulence through modifying their gene function.
- 23 April 2020
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 16 (4) , e1008469
Open AccessNon-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter
The molecular mechanisms that allow pathogenic bacteria to infect animals have been intensively studied. On the other hand, the molecular mechanisms by which bacteria acquire virulence functions are not fully understood. In the present study, we experimentally evaluated the evolution of a non-pathogenic strain of Escherichia coli in a silkworm infection model and obtained pathogenic mutant strains. As one cause of the high virulence properties of E. coli mutants, we identified amino acid substitutions in LptD (G580S) and LptE (T95I) constituting the lipopolysaccharide (LPS) transporter, which translocates LPS from the inner to the outer membrane and is essential for E. coli growth. The growth of the LptD and LptE mutants obtained in this study was indistinguishable from that of the parent strain. The LptD and LptE mutants exhibited increased secretion of outer membrane vesicles containing LPS and resistance against various antibiotics, antimicrobial peptides, and host complement. In vivo cross-linking studies revealed that the conformation of the LptD-LptE complex was altered in the LptD and LptE mutants. Furthermore, several clinical isolates of E. coli carried amino acid substitutions of LptD and LptE that conferred resistance against antimicrobial substances. This study demonstrated an experimental evolution of bacterial virulence properties in an animal infection model and identified functional alterations of the growth-essential LPS transporter that led to high bacterial virulence by conferring resistance against antimicrobial substances. These findings suggest that non-pathogenic bacteria can gain virulence traits by changing the functions of essential genes, and provide new insight to bacterial evolution in a host environment. Pathogenic bacteria developed their virulence properties by changing the functions of various genes after the emergence of the host animals on earth. The types of gene function alterations that confer bacterial virulence properties, however, have remained unclear. We utilized a silkworm infection model to perform an experimental evolution of bacterial virulence activity. From a non-pathogenic strain of Escherichia coli, we obtained a mutant strain that exhibited 500-fold higher virulence than the original strain and identified mutations of the lipopolysaccharide (LPS) transporter, which translocates LPS onto the bacterial surface, as one cause of the high virulence. The mutations changed the structure of the LPS transporter, increased the secretion of outer membrane vesicles, and enabled bacterial survival in the presence of host antimicrobial substances. This mechanism to gain high virulence occurs naturally, as several E. coli clinical isolates carried mutations of the LPS transporter that confer resistance against antimicrobial substances. Our study unveiled a novel mechanism by which bacteria increase their virulence through modifying their gene function.
- 20 August 2010
- Published by Wiley in FEBS Letters
- Vol. 584 (18) , 4041-4047
Alternative splicing of genes during neuronal differentiation of NT2 pluripotential human embryonal carcinoma cells
We analyzed the mRNA diversity of genes after inducing neuronal differentiation in human NT2 teratocarcinoma cells using all‐trans retinoic acid (RA). DNA microarray analyses of cells treated with RA identified 358 RA‐responsive genes. mRNA diversity analysis revealed that 274 genes produced multiple protein‐coding transcripts by alternative splicing. Among these 274 genes, we chose 26 genes that showed AS in their C‐terminus and 12 transcription factor genes for further analysis. By using transcript‐specific primers, we performed quantitative real‐time PCR analysis to examine the expression profiles of all the protein‐coding transcripts. Consequently, we identified genes which showed different RA‐induced changes in the expression of their protein‐coding transcripts.
- 20 August 2010
- Published by Wiley in FEBS Letters
- Vol. 584 (18) , 4041-4047
Alternative splicing of genes during neuronal differentiation of NT2 pluripotential human embryonal carcinoma cells
We analyzed the mRNA diversity of genes after inducing neuronal differentiation in human NT2 teratocarcinoma cells using all‐trans retinoic acid (RA). DNA microarray analyses of cells treated with RA identified 358 RA‐responsive genes. mRNA diversity analysis revealed that 274 genes produced multiple protein‐coding transcripts by alternative splicing. Among these 274 genes, we chose 26 genes that showed AS in their C‐terminus and 12 transcription factor genes for further analysis. By using transcript‐specific primers, we performed quantitative real‐time PCR analysis to examine the expression profiles of all the protein‐coding transcripts. Consequently, we identified genes which showed different RA‐induced changes in the expression of their protein‐coding transcripts.
- 10 August 2003
- Published by Springer Nature in Nature Medicine
- Vol. 9 (9) , 1166-1172
Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities
The discovery of endogenous bioactive peptides has typically required a lengthy identification process. Computer-assisted analysis of cDNA and genomic DNA sequence information can markedly shorten the process. A bioinformatic analysis of full-length, enriched human cDNA libraries searching for previously unidentified bioactive peptides resulted in the identification and characterization of two related peptides of 28 and 20 amino acids, which we designated salusin-α and salusin-β. Salusins are translated from an alternatively spliced mRNA of TOR2A, a gene encoding a protein of the torsion dystonia family. Intravenous administration of salusin-α or salusin-β to rats causes rapid, profound hypotension and bradycardia. Salusins increase intracellular Ca2+, upregulate a variety of genes and induce cell mitogenesis. Salusin-β stimulates the release of arginine-vasopressin from rat pituitary. Expression of TOR2A mRNA and its splicing into preprosalusin are ubiquitous, and immunoreactive salusin-α and salusin-β are detected in many human tissues, plasma and urine, suggesting that salusins are endocrine and/or paracrine factors.
- 10 August 2003
- Published by Springer Nature in Nature Medicine
- Vol. 9 (9) , 1166-1172
Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities
The discovery of endogenous bioactive peptides has typically required a lengthy identification process. Computer-assisted analysis of cDNA and genomic DNA sequence information can markedly shorten the process. A bioinformatic analysis of full-length, enriched human cDNA libraries searching for previously unidentified bioactive peptides resulted in the identification and characterization of two related peptides of 28 and 20 amino acids, which we designated salusin-α and salusin-β. Salusins are translated from an alternatively spliced mRNA of TOR2A, a gene encoding a protein of the torsion dystonia family. Intravenous administration of salusin-α or salusin-β to rats causes rapid, profound hypotension and bradycardia. Salusins increase intracellular Ca2+, upregulate a variety of genes and induce cell mitogenesis. Salusin-β stimulates the release of arginine-vasopressin from rat pituitary. Expression of TOR2A mRNA and its splicing into preprosalusin are ubiquitous, and immunoreactive salusin-α and salusin-β are detected in many human tissues, plasma and urine, suggesting that salusins are endocrine and/or paracrine factors.
- 1 January 1994
- Published by Elsevier in Journal of Fermentation and Bioengineering
- Vol. 77 (6) , 591-597
A novel 7-β-(4-carboxybutanamido)-cephalosporanic acid acylase isolated from Pseudomonas strain C427 and its high-level production in Escherichia coli
- 1 January 1994
- Published by Elsevier in Journal of Fermentation and Bioengineering
- Vol. 77 (6) , 591-597
A novel 7-β-(4-carboxybutanamido)-cephalosporanic acid acylase isolated from Pseudomonas strain C427 and its high-level production in Escherichia coli
- 1 January 1991
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 55 (8) , 2163-2165
Direct Production of 7-Aminodeacetylcephalosporanic Acid by Acremonium chrysogenum Hum178.
- 1 January 1991
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 55 (8) , 2163-2165
Direct Production of 7-Aminodeacetylcephalosporanic Acid by Acremonium chrysogenum Hum178.
- 1 January 1991
- Published by The Society for Actinomycetes Japan in Actinomycetologica
- Vol. 5 (2) , 102-111
Direct Production of 7-Aminocephalosporanic Acid and 7-Aminodeacetyl-cephalosporanic Acid by Recombinant Acremonium chrysogenum.
- 1 January 1991
- Published by The Society for Actinomycetes Japan in Actinomycetologica
- Vol. 5 (2) , 102-111
Direct Production of 7-Aminocephalosporanic Acid and 7-Aminodeacetyl-cephalosporanic Acid by Recombinant Acremonium chrysogenum.
- 1 January 1987
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 51 (9) , 2321-2329
Transformation of Acremonium chrysogenum and Saccharomyces cerevisiae using an antibiotic resistance marker.
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 1987
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 51 (9) , 2321-2329
Transformation of Acremonium chrysogenum and Saccharomyces cerevisiae using an antibiotic resistance marker.
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 1 January 1986
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 50 (4) , 819-825
Protein synthesis in adenovirus E1A transformed cells.
- 1 January 1986
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 50 (4) , 819-825
Protein synthesis in adenovirus E1A transformed cells.
- 1 January 1984
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 48 (8) , 1985-1990
Construction of phage vectors in Streptomyces: Introduction of the thiostreptone resistant (tsr) gene into R4 phage.
- 1 January 1984
- Published by Oxford University Press (OUP) in Agricultural and Biological Chemistry
- Vol. 48 (8) , 1985-1990
Construction of phage vectors in Streptomyces: Introduction of the thiostreptone resistant (tsr) gene into R4 phage.